Homopolymer switches mediate adaptive mutability in mismatch repair-deficient colorectal cancer
-
Published:2024-07
Issue:7
Volume:56
Page:1420-1433
-
ISSN:1061-4036
-
Container-title:Nature Genetics
-
language:en
-
Short-container-title:Nat Genet
Author:
Kayhanian Hamzeh, Cross WilliamORCID, van der Horst Suzanne E. M., Barmpoutis PanagiotisORCID, Lakatos Eszter, Caravagna GiulioORCID, Zapata Luis, Van Hoeck ArneORCID, Middelkamp Sjors, Litchfield Kevin, Steele Christopher, Waddingham William, Patel DominicORCID, Milite SalvatoreORCID, Jin ChenORCID, Baker Ann-MarieORCID, Alexander Daniel C.ORCID, Khan Khurum, Hochhauser Daniel, Novelli Marco, Werner BenjaminORCID, van Boxtel RubenORCID, Hageman Joris H., Buissant des Amorie Julian R., Linares Josep, Ligtenberg Marjolijn J. L.ORCID, Nagtegaal Iris D.ORCID, Laclé Miangela M., Moons Leon M. G., Brosens Lodewijk A. A.ORCID, Pillay NischalanORCID, Sottoriva AndreaORCID, Graham Trevor A.ORCID, Rodriguez-Justo ManuelORCID, Shiu Kai-Keen, Snippert Hugo J. G.ORCID, Jansen MarnixORCID
Abstract
AbstractMismatch repair (MMR)-deficient cancer evolves through the stepwise erosion of coding homopolymers in target genes. Curiously, the MMR genes MutS homolog 6 (MSH6) and MutS homolog 3 (MSH3) also contain coding homopolymers, and these are frequent mutational targets in MMR-deficient cancers. The impact of incremental MMR mutations on MMR-deficient cancer evolution is unknown. Here we show that microsatellite instability modulates DNA repair by toggling hypermutable mononucleotide homopolymer runs in MSH6 and MSH3 through stochastic frameshift switching. Spontaneous mutation and reversion modulate subclonal mutation rate, mutation bias and HLA and neoantigen diversity. Patient-derived organoids corroborate these observations and show that MMR homopolymer sequences drift back into reading frame in the absence of immune selection, suggesting a fitness cost of elevated mutation rates. Combined experimental and simulation studies demonstrate that subclonal immune selection favors incremental MMR mutations. Overall, our data demonstrate that MMR-deficient colorectal cancers fuel intratumor heterogeneity by adapting subclonal mutation rate and diversity to immune selection.
Funder
Cancer Research UK Rosetrees Trust
Publisher
Springer Science and Business Media LLC
Reference59 articles.
1. Kunkel, T. A. & Erie, D. A. DNA mismatch repair. Annu. Rev. Biochem. 74, 681–710 (2005). 2. De Wind, N. et al. HNPCC-like cancer predisposition in mice through simultaneous loss of Msh3 and Msh6 mismatch-repair protein functions. Nat. Genet. 23, 359–362 (1999). 3. Sanders, M. A. et al. Life without mismatch repair. Preprint at bioRxiv https://doi.org/10.1101/2021.04.14.437578 (2021). 4. Fang, H. et al. Deficiency of replication-independent DNA mismatch repair drives a 5-methylcytosine deamination mutational signature in cancer. Sci. Adv. 7, eabg4398 (2021). 5. Zou, X. et al. A systematic CRISPR screen defines mutational mechanisms underpinning signatures caused by replication errors and endogenous DNA damage. Nat. Cancer 2, 643–657 (2021).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|